Incentives for Global Health (IGH) is a non-profit organization dedicated to developing market-based, systemic solutions to health challenges faced by the world's poor.
The Health Impact Fund Initiative
IGH's main project, the Health Impact Fund, aims to increase access to medicines by creating additional incentives for innovation in the health sector. Choosing to register a new drug with the Fund, the patent holder would be rewarded for ten years through treaty-backed payments proportional to this drug's global health impact. In exchange, patent holders agree to sell the drug at a designated low price and to offer zero-priced licenses for manufacturing and selling the product after the conclusion of the reward period.
For more detailed information on Health Impact Fund, click here.
Who We Are
Incentives for Global Health is led by Dr. Thomas Pogge of the Center for Applied Philosophy and Public Ethics at Australian National University, Canberra and supported by the BUPA Foundation and the Australian Research Council. Dr. Pogge's work has been supported by the John D. and Catherine T. MacArthur Foundation, the Princeton Institute for Advanced Study, and All Souls College (Oxford).
Click here for more information about Dr. Pogge and the IGH team.
